A new drug tested at University of Colorado Hospital can cure most patients with Hepatitis C within 12 weeks, researchers say.
Leukemia patients in clinical trials at Anschutz are taking advantage of life-saving drugs made available by new federal legislation.
A two-drug therapy that blocks separate melanoma growth pathways is helping patients at CU Cancer Center.
A study founded in 1993 with 30,000 participants is helping CU's Barbara Davis Center answer the question: Why do some people get Type 1 diabetes?
Women make up fewer than one-third of researchers and engineers nationally; a CU advocate says attempts to attract girls to these fields needs to start early.
Why does exercise help some but not all people lose weight? That's what CU researchers plan to find out.
Most kids consume caffeine, but how do you know how much is safe?
Cancer warning don't increase teen use of sunscreen, but PSAs showing that sun causes aging will.
Your "weight fate" is set by age 5, a new study shows, meaning day care and preschools need to get involved in diet and exercise, a CU physician says.
A research project that aims for more targeted therapies for melanoma has been made possible by a $5 million anonymous gift.
Pacemakers and defibrillators can keep very ill people alive against their will. A CU palliative care physician says doctors need to talk to patients about end of life when inserting the devices.
Adult vaccination rates remain stubbornly low but CU researchers have found that doctors rarely discuss the 11 recommended vaccines with their patients.
School of Medicine researchers will team with the Boulder campus to develop ways to more quickly determine how drugs and biological and chemical agents affect humans.
The CU and Duke University schools of medicine have received a $10 million grant for work with the Palliative Care Research Cooperative Group over the next five years.
Researchers predict 2014 developments in prostate cancer research and treatment.